OR WAIT 15 SECS
© 2020 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
© 2020 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
March 01, 2011
Castellani Takes Charge at PhRMA
Boehringer Ingelheim's PICASSO program helps it focus on engaging industry stakeholders to improve patient care
Despite its dimunitive size, the pharmaceutical industry looks to the Netherlands for a world-class medical infrastructure, new standards in innovation, and a closely-knit community of stakeholders
Ferring finds a new approach to communicate its value offering
Ipsen is redefining a standard for success in innovation with its local Dutch affiliate
With an emphasis on short-term objectives rather than long-term goals, pharma is missing a huge opportunity in applying market science to drive adherence
A highlight of the Hay Group's annual study of Sales Force Effectiveness, focusing on managed care markets
When dealing with the pharmaceutical marketplace, why is keeping things simple so complex?
Pharma can be an insular industry, with limited capacity to gaze beyond its own narrow frame of vision
Pharm Exec's annual feature applauding the people behind the best of pharma advertising over the past year
Negative views regarding pharma are on the rise, but vaccines help keep the focus on the positives of innovation
FDA's Sentinel Initiative raises broader questions about tapping patient information and health IT for comparative studies in drug development
The Federal Circuit court continues its trend in tightening the standards for establishing patent damages by leapfrogging a stalled legislative process
A sneak preview of The Avoca Group's 2011 Annual Survey on CRO and Industry Relationships
Can PhRMA's own business model synch with industry's Pharm Exec takes a closer look at PhRMA's new leadership.